This bill, known as the Epstein Files Transparency Act II, strengthens the ability of state attorneys general, district attorneys, and victims to legally challenge the U.S. Attorney General for withholding or redacting records related to the Jeffrey Epstein investigation. It grants these parties the right to sue in federal court to force the release of unredacted documents, including classified materials, while requiring courts to expedite these cases. The legislation clarifies that federal agencies cannot use standard legal privileges to hide relevant evidence and explicitly defines who qualifies as a victim for the purposes of accessing these files. Additionally, it ensures that state and local law enforcement can use the released information in their own investigations without being restricted by federal privacy regulations.
The Cancer Drug Parity Act of 2026 requires group health plans and insurance coverage to treat the cost-sharing for oral cancer medications no less favorably than that for intravenously administered cancer drugs. This rule applies to FDA-approved oral cancer treatments that a treating physician deems medically necessary and clinically appropriate, ensuring that deductibles, copayments, and coinsurance rates are not higher for oral options. The legislation also prohibits plans from making changes that would increase out-of-pocket costs or impose stricter limitations on oral cancer drugs compared to injected ones, while still allowing for standard utilization controls like prior authorization. Additionally, the bill mandates a Government Accountability Office study within two years to assess the impact of these changes on patient costs and access.
The Duster Inhalation Prevention Act directs the Consumer Product Safety Commission to classify specific aerosol duster propellants as hazardous substances. Under this law, aerosol products containing more than 18 mg of these substances would be banned, and manufacturers would be prohibited from stockpiling them ahead of the ban. The bill also allows the Commission to add other harmful propellants to the list if they are used for recreational inhalation. These measures aim to reduce the availability of products that can be misused for intoxication while excluding FDA-regulated drugs from the restrictions.
The Luxury JET Act prohibits the use of a luxury aircraft donated by the Government of Qatar for the personal benefit of any President, their family members, or associates, even after their term ends. It also mandates that the Government Accountability Office conduct a detailed review of the aircraft donation to analyze potential conflicts of interest, the full cost to taxpayers, and the legality of accepting the gift under the Foreign Emoluments Clause. The report from this review must be submitted to congressional defense committees within 90 days and should include recommendations to improve laws regarding foreign gifts and prevent the misuse of taxpayer funds.
The Nitrous Oxide Inhalation Prevention Act establishes new federal regulations to curb the misuse of nitrous oxide while allowing its continued use for legitimate medical, industrial, and automotive purposes. Key provisions include banning flavored products and limiting food-use canisters to 8 grams, alongside strict rules that prohibit packaging with bright colors or cartoon characters and require prominent warning labels on every cartridge. The bill also imposes age restrictions by setting a minimum purchase age of 21, mandates that retailers verify identification and limit sales hours, and restricts wholesalers from selling directly to individual consumers. To support harm reduction efforts, the legislation authorizes funding for grants aimed at education, prevention programs, and training for law enforcement and medical professionals. Non-compliance with these new requirements can result in civil monetary penalties for manufacturers and distributors, or escalating fines and potential sales bans for retailers.
The Agricultural Worker Justice Act of 2026 establishes new rules to improve wages, safety, and accountability for workers in the meat and poultry processing industry. It requires the USDA to only purchase food from facilities where workers are paid at least the local prevailing wage and prohibits companies receiving USDA funds from buying back their own stock or paying dividends. The bill also mandates stricter safety standards, including limits on increased production line speeds, better access to toilet facilities, and enhanced protections against retaliation for reporting injuries or unsafe conditions. Additionally, the legislation creates a system to blacklist contractors with repeated labor law violations and requires detailed annual reports on grant recipients and racial disparities in the sector.
The McCarty and Heideman Air Safety Enhancement Act directs the Federal Aviation Administration to review its policies on low-altitude airspace safety, specifically focusing on hazards created by temporary structures like slacklines and highlines. This review will involve consulting with various aviation stakeholders, including pilots, drone operators, and land management agencies, to assess current marking requirements and data accuracy. If the FAA finds that existing rules are insufficient, it must update regulations within a year to better identify these obstructions in flight planning tools and improve coordination with local authorities. Additionally, the agency is required to report its findings and any recommended policy changes to Congress within nine months of completing the review.
This bill, known as the Daughters of the American Revolution Membership Integrity Act, amends federal law to explicitly limit membership in the Daughters of the American Revolution to adult human females. It defines a female as someone who naturally possesses or would have the reproductive system capable of producing ova for fertilization, regardless of any congenital anomalies or medical disruptions. By adding this specific definition to the organization's governing code, the legislation clarifies the genealogical and biological requirements for joining the group. The change directly affects the organization's eligibility rules but does not alter its internal operations or funding.
The Drug Deal Disclosure Act requires the Department of Health and Human Services to publicly release records of specific agreements between the federal government and major drug manufacturers starting in 2025. These agreements must include provisions such as offering lower drug prices based on international rates, providing discounts through government platforms like TrumpRx, or receiving special exemptions from import duties and regulatory reviews. While the bill mandates that most documents be made available in a searchable format, it allows the government to withhold only specific confidential pricing details if legally required by foreign laws or court orders, provided a justification is published. Additionally, the law directs the Congressional Budget Office and the Government Accountability Office to analyze the economic and budgetary impacts of these deals, including effects on Medicare, Medicaid, and drug competition.
The McCarty and Heideman Air Safety Enhancement Act directs the Federal Aviation Administration to review its policies on low-altitude airspace safety, specifically focusing on hazards created by temporary obstructions like slacklines and highlines. This review must involve various aviation stakeholders and examine whether current rules for marking, lighting, and reporting these obstacles are effective in preventing aircraft strikes. If the FAA finds existing guidelines insufficient, it is required to update regulations within a year to improve how these hazards are depicted in flight planning tools and communicated to pilots. Additionally, the agency must report its findings and any proposed rule changes to Congress within 90 days of completing the review.
The Patients First Act of 2026 modifies how Medicare reimburses physicians and primary care providers to improve access and stabilize payments. It establishes a new hybrid payment model for primary care services from 2027 to 2031, which pays a monthly fee per patient to eligible independent practices while covering specific services like care management and telehealth without cost-sharing for patients. The bill also updates the formula for calculating reimbursement rates to account for high inflation years and requires more frequent updates to the costs used in calculating payments. Additionally, the legislation reforms the performance-based payment system by adding care efficiency measures, creating a task force to recommend new quality metrics, and adjusting penalties for providers who fail to report on certain data.
The Essential Caregivers Act of 2026 requires nursing homes, long-term care hospitals, rehabilitation facilities, and intermediate care facilities to allow two chosen family members or friends to visit residents during times when regular visitation is suspended. These essential caregivers must agree to follow the facility's existing safety and infection control rules, which are no more restrictive than those applied to staff. While facilities can limit access for the first seven days of a suspension or deny entry if a caregiver shows symptoms of a serious infectious disease, they cannot block visits for end-of-life care. Additionally, the bill mandates that complaints about denied access to essential caregivers be investigated and resolved within three days.
